Bavarian Nordic

Bavarian Nordic is a Danish biotechnology company based in Hellerup, Denmark.

On May 6, 2022, the company was awarded a contract by the Public Health Agency of Canada (PHAC) to provide 500,000 units of Imvamune to the Canadian stockpile. The tender announcement described the purchase as being in anticipation of a potential accidental or intentional release of smallpox.

Bavarian Nordic manufactures a smallpox vaccine product named Imvamune (Canada), Imvanex (Europe), or Jynneos (United States of America).